de Rocafiguera, C.; Belsa, B.; Font-Bardia, M.; Puigjaner, C.; Serra, E.; Cuartero-Albesa, A.M.; Puig de la Bellacasa, R.; Borrell, J.I.
When Unsuspected Crystallinity Ruins Biological Testing in Early Discovery: A Case Study. Pharmaceuticals 2024, 17, 284.
https://doi.org/10.3390/ph17030284
AMA Style
de Rocafiguera C, Belsa B, Font-Bardia M, Puigjaner C, Serra E, Cuartero-Albesa AM, Puig de la Bellacasa R, Borrell JI.
When Unsuspected Crystallinity Ruins Biological Testing in Early Discovery: A Case Study. Pharmaceuticals. 2024; 17(3):284.
https://doi.org/10.3390/ph17030284
Chicago/Turabian Style
de Rocafiguera, Claudi, Blanca Belsa, Mercè Font-Bardia, Cristina Puigjaner, Eduard Serra, Ana M. Cuartero-Albesa, Raimon Puig de la Bellacasa, and José I. Borrell.
2024. "When Unsuspected Crystallinity Ruins Biological Testing in Early Discovery: A Case Study" Pharmaceuticals 17, no. 3: 284.
https://doi.org/10.3390/ph17030284
APA Style
de Rocafiguera, C., Belsa, B., Font-Bardia, M., Puigjaner, C., Serra, E., Cuartero-Albesa, A. M., Puig de la Bellacasa, R., & Borrell, J. I.
(2024). When Unsuspected Crystallinity Ruins Biological Testing in Early Discovery: A Case Study. Pharmaceuticals, 17(3), 284.
https://doi.org/10.3390/ph17030284